Correction to “Infantile Krabbe disease (0–12 months), progression, and recommended endpoints for clinical trials”

IF 3.9 2区 医学 Q1 CLINICAL NEUROLOGY Annals of Clinical and Translational Neurology Pub Date : 2025-01-09 DOI:10.1002/acn3.52275
{"title":"Correction to “Infantile Krabbe disease (0–12 months), progression, and recommended endpoints for clinical trials”","authors":"","doi":"10.1002/acn3.52275","DOIUrl":null,"url":null,"abstract":"<p>Article AID: ACN352114</p><p>\n <b>Table 1</b>\n </p><p>On Page 4, age at first evaluation for HSCT asymptomatic group should have a maximum of 40.7 not 40.1.</p><p>For initial psychosine levels, please update natural history median to 22.3 and range to 0.99–82.3, symptomatic HSCT median to 28.1 and range to 4.09–54.0, and asymptomatic HSCT range to 1.03–29.1.</p><p>For initial GALC levels, please update symptomatic HSCT median to 0.01 and asymptomatic HSCT range to 0.02–0.23.</p><p>\n <b>Table 2</b>\n </p><p>On Page 5, please update heading to say, “Summary of the growth percentiles in Natural History, Symptomatic HSCT, and Asymptomatic HSCT patients, indicating percentages below the third percentile for head circumference and below the fifth percentile for height, weight, and body mass index.”</p><p>\n <b>Sitting</b>\n </p><p>On Page 8, please update the last sentence from “52%” to “53%,” and replace “Table S6” with “Table S7” in the last sentence.</p><p>\n <b>Neurodevelopmental Function</b>\n </p><p>On Pages 10–11, the last sentence in the first paragraph of Page 11 (“<i>The Asympt HSCT group showed higher scores and greater gains over time than both the NH and Sympt HSCT groups for all domains (all p &lt; 0.001) (Table</i> <i>S9</i><i>)</i>.”) needs to be moved to Page 10 just after “<i>(Figs</i>. <i>S2</i> <i>and</i> <i>S3</i>, <i>Table</i> <i>S8</i><i>)</i>.” and before “<i>The group performed slightly better…</i>.”</p><p>\n <b>Supporting Information</b>\n </p><p><span>Table</span> <span>S4</span></p><p>Table S4 is incorrectly listed as Table S5.</p><p><span>Tables</span> <span>S7</span>, <span>S8</span>, <span>and</span> <span>S9</span></p><p>Table S7 is incorrectly listed as Table S9. Table S8 is incorrectly listed as Table S7. Table S9 is incorrectly listed as Table S8.</p><p>Additionally, the tables and figures under Supporting Information do not have numbers or legends when downloaded. To address all issues, we have prepared new, reformatted PDFs with correct figure numbers and legends to be included in Supporting Information. Please just replace those files with the new ones provided. Thank you!</p><p>We apologize for these errors.</p>","PeriodicalId":126,"journal":{"name":"Annals of Clinical and Translational Neurology","volume":"12 2","pages":"455"},"PeriodicalIF":3.9000,"publicationDate":"2025-01-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/acn3.52275","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annals of Clinical and Translational Neurology","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/acn3.52275","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Article AID: ACN352114

Table 1

On Page 4, age at first evaluation for HSCT asymptomatic group should have a maximum of 40.7 not 40.1.

For initial psychosine levels, please update natural history median to 22.3 and range to 0.99–82.3, symptomatic HSCT median to 28.1 and range to 4.09–54.0, and asymptomatic HSCT range to 1.03–29.1.

For initial GALC levels, please update symptomatic HSCT median to 0.01 and asymptomatic HSCT range to 0.02–0.23.

Table 2

On Page 5, please update heading to say, “Summary of the growth percentiles in Natural History, Symptomatic HSCT, and Asymptomatic HSCT patients, indicating percentages below the third percentile for head circumference and below the fifth percentile for height, weight, and body mass index.”

Sitting

On Page 8, please update the last sentence from “52%” to “53%,” and replace “Table S6” with “Table S7” in the last sentence.

Neurodevelopmental Function

On Pages 10–11, the last sentence in the first paragraph of Page 11 (“The Asympt HSCT group showed higher scores and greater gains over time than both the NH and Sympt HSCT groups for all domains (all p < 0.001) (Table S9).”) needs to be moved to Page 10 just after “(Figs. S2 and S3, Table S8).” and before “The group performed slightly better….”

Supporting Information

Table S4

Table S4 is incorrectly listed as Table S5.

Tables S7, S8, and S9

Table S7 is incorrectly listed as Table S9. Table S8 is incorrectly listed as Table S7. Table S9 is incorrectly listed as Table S8.

Additionally, the tables and figures under Supporting Information do not have numbers or legends when downloaded. To address all issues, we have prepared new, reformatted PDFs with correct figure numbers and legends to be included in Supporting Information. Please just replace those files with the new ones provided. Thank you!

We apologize for these errors.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
修正为“婴儿克拉伯病(0-12个月)、进展和推荐的临床试验终点”。
表1在第4页,HSCT无症状组的首次评估年龄应该最大为40.7,而不是40.1。对于初始精神病水平,请将自然病史中位数更新为22.3,范围为0.99-82.3,有症状的HSCT中位数为28.1,范围为4.09-54.0,无症状的HSCT范围为1.03-29.1。对于初始GALC水平,请将有症状的HSCT中位数更新为0.01,无症状的HSCT范围更新为0.02-0.23。表2在第5页,请更新标题,“自然史、症状性造血干细胞移植和无症状性造血干细胞移植患者的生长百分位数总结,表明头围低于第三百分位数的百分比,身高、体重和体重指数低于第五百分位数的百分比。”在第8页,请将最后一句“52%”改为“53%”,并将最后一句的“Table S6”改为“Table S7”。在第10 - 11页,第11页第一段的最后一句话(“随着时间的推移,与NH和Sympt HSCT组相比,Asympt HSCT组在所有领域(p < 0.001)(表S9)都显示出更高的分数和更大的收益。”)需要移到第10页。S2和S3,表S8)。,然后是“这组表现稍好一点....”。表S4被错误地列为表S5。表S7、表S8和表S9表S7被错误地列为表S9。表S8被错误地列为表S7。表S9被错误地列为表S8。此外,“支持资料”下的表格和图表在下载时没有数字或图例。为了解决所有问题,我们准备了新的,重新格式化的pdf,其中包含正确的数字和图例,以包含在支持信息中。请将这些文件替换为提供的新文件。谢谢你!我们为这些错误道歉。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Annals of Clinical and Translational Neurology
Annals of Clinical and Translational Neurology Medicine-Neurology (clinical)
CiteScore
9.10
自引率
1.90%
发文量
218
审稿时长
8 weeks
期刊介绍: Annals of Clinical and Translational Neurology is a peer-reviewed journal for rapid dissemination of high-quality research related to all areas of neurology. The journal publishes original research and scholarly reviews focused on the mechanisms and treatments of diseases of the nervous system; high-impact topics in neurologic education; and other topics of interest to the clinical neuroscience community.
期刊最新文献
CX3CL1 in Early Detection of Alzheimer's Disease: Plasma Dynamics Across Age and Disease Stages. Shared Genetic Effects and Antagonistic Pleiotropy Between Multiple Sclerosis and Common Cancers. Association of CDKN2A/B Homozygous Deletion and Extent of Resection With Survival of Patients With WHO CNS5 Grade 4 Astrocytoma. Meningovascular Inflammation in Cerebral Amyloid Angiopathy-Related Cortical Superficial Siderosis. Fluid and Neuroimaging Biomarkers in Microgliopathy Colony-Stimulating Factor-1 Receptor-Related Disorders.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1